Sulfisomidine

磺胺索嘧啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfisomidine
Drug Alias Name二甲基嘧啶sulfisomidine磺胺二甲乙醚啶sulfisomidina磺胺二甲异嘧啶 +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsUterine CervicitisUrethritisConjunctivitis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsUterine CervicitisUrethritisConjunctivitis +[5
Inactive IndicationsN/A

Other Information

ATC CodeJ01EB01
Related LinksWikipediaKEGG